— Know what they know.
Not Investment Advice

SNNC OTC

Sibannac, Inc.
1W: +11.1% 1M: -31.0% 3M: -33.3% YTD: -68.0% 1Y: -72.4% 3Y: -81.5% 5Y: -96.7%
$0.00
+0.00 (+14.29%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 43 · $123500 mcap · 10M float · 3.25% daily turnover · Short 33% of daily vol

Balance Sheet Trends

Total Assets
$801K +8.5% ▲
5Y CAGR: +36.2%
Total Liabilities
$2M +3.8% ▲
5Y CAGR: +1.3%
Shareholders Equity
-$718K +0.9% ▲
Cash & Investments
$8K +1524.0% ▲
5Y CAGR: -21.2%
Total Debt
$647K +14.5% ▲
5Y CAGR: -3.3%
Net Debt
$639K +13.2% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$41K$14K$7$500$8K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$41K$14K$7$500$8K
Net Receivables$19K$4K$4K$5K$5K
Inventory$24K$21K$36K$35K$35K
Other Current Assets$0$0$0$0$0
Total Current Assets$84K$40K$40K$40K$48K
Property, Plant & Equip.$8K$8K$6K$6K$6K
Goodwill & Intangibles$330K$330K$330K$598K$598K
Long-Term Investments$500K$505K$797K$34K$89K
Other Non-Current Assets-$331K-$331K$5K$60K$60K
Total Non-Current Assets$838K$843K$1M$698K$753K
Total Assets$922K$882K$1M$738K$801K
— Liabilities —
Accounts Payable$611K$12K$68K$78K$95K
Short-Term Debt$73K$12K$0$0$13K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$479K$171K$249K$329K$136K
Total Current Liabilities$2M$294K$520K$770K$780K
Long-Term Debt$464K$312K$629K$565K$634K
Other Non-Current Liab.$71K$44K$0$128K$105K
Total Non-Current Liabilities$535K$356K$629K$693K$739K
Total Liabilities$2M$650K$1M$1M$2M
— Equity —
Common Stock$26K$78K$110K$110K$114K
Retained Earnings-$4M-$4M-$5M-$6M-$6M
Accumulated OCI-$26K$67K$76K$76K$84K
Total Stockholders Equity-$1M$233K$30K-$725K-$718K
Total Liabilities & Equity$922K$882K$1M$738K$801K
— Key Metrics —
Total Debt$537K$324K$629K$565K$647K
Net Debt$496K$310K$629K$565K$639K
Total Investments$500K$505K$797K$34K$89K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms